---
id: viral-meningitis_085
category: clinical_syndromes
tags: [viral-meningitis, enterovirus, HSV-2, aseptic-meningitis, CSF-findings]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Viral (Aseptic) Meningitis

**Q:** What are the causes, CSF findings, diagnostic approach, and management of viral (aseptic) meningitis?

**A:**

**Definition:**
- **Aseptic Meningitis:** Meningeal inflammation with **negative routine bacterial cultures**
- **Most common etiology: Viral** (85-95% of aseptic meningitis)

---

## EPIDEMIOLOGY

**Incidence:**
- **10-20 cases per 100,000** (much higher than bacterial meningitis)
- **Most common in summer/fall** (enterovirus season)

**Prognosis:**
- **Benign, self-limited** (vs bacterial meningitis)
- **Mortality <1%**
- **Full recovery in >95%**

**Key Point:** **Viral meningitis = benign prognosis** (vs 10-30% mortality in bacterial)

---

## ETIOLOGY

---

### **1. Enteroviruses (#1 CAUSE - 85-90% of Viral Meningitis)**

**Viruses:**
- **Coxsackievirus A, B**
- **Echovirus**
- **Enterovirus 71** (associated with brainstem encephalitis in Asia)
- **Parechoviruses** (neonates)

**Epidemiology:**
- **Peak:** Summer and fall (June-October)
- **Transmission:** Fecal-oral, respiratory droplets

**Clinical Features:**
- **Prodrome:** Upper respiratory symptoms, GI symptoms (diarrhea, vomiting)
- **Rash:** Maculopapular, petechial (coxsackievirus, echovirus)
- **Hand-foot-mouth disease:** Coxsackievirus A16, enterovirus 71
- **Herpangina:** Posterior pharyngeal vesicles (coxsackievirus)

**Key Point:** **Enteroviruses = #1 cause** (85-90%), peak in summer/fall

---

### **2. Herpes Simplex Virus (HSV)**

**HSV-2 >> HSV-1:**
- **HSV-2** (genital herpes) - **Most common cause of recurrent aseptic meningitis** (Mollaret meningitis)
- **HSV-1** (oral herpes) - Less common (usually causes encephalitis, not meningitis)

**Clinical Features:**
- **Primary genital herpes:** Meningitis in 10-30% (during first HSV-2 outbreak)
- **Recurrent HSV-2 meningitis (Mollaret meningitis):**
  - **Episodic aseptic meningitis** (recurrent episodes)
  - **Self-limited** (2-7 days)
  - **No encephalitis features** (normal cognition)

**Key Point:** **HSV-2 = recurrent aseptic meningitis** (Mollaret), **HSV-1 = encephalitis** (NOT meningitis)

---

### **3. Varicella-Zoster Virus (VZV)**

**Clinical Features:**
- **Associated with zoster (shingles)** or primary varicella
- **May occur WITHOUT rash** (zoster sine herpete)
- **Complications:** Vasculopathy (stroke), myelitis

---

### **4. Arboviruses (Summer/Fall, Geographic)**

**West Nile Virus (WNV):**
- **Most common arboviral CNS infection in US**
- **Summer/fall** (mosquito season)
- **Can cause meningitis, encephalitis, or acute flaccid paralysis**

**Other Arboviruses:**
- **St. Louis encephalitis virus**
- **La Crosse virus** (pediatric)
- **Eastern equine encephalitis** (EEE - severe)

---

### **5. HIV (Acute HIV Syndrome)**

**Clinical Features:**
- **Acute retroviral syndrome:** Fever, rash, lymphadenopathy, pharyngitis
- **Aseptic meningitis** in 10-20% during acute HIV

**Diagnosis:**
- **HIV RNA PCR** (positive during acute infection)
- **HIV antibody:** May be negative (seroconversion window)

---

### **6. Lymphocytic Choriomeningitis Virus (LCMV)**

**Transmission:**
- **Rodent exposure** (mice, hamsters) - urine, feces

**Clinical Features:**
- **Biphasic illness:** Flu-like prodrome → meningitis
- **Winter/spring** (rodent season)

---

### **7. Mumps**

**Epidemiology:**
- **Rare** (due to MMR vaccination)
- **Unvaccinated populations** (outbreaks)

**Clinical Features:**
- **Parotitis** (50-70% of cases) - but can have meningitis WITHOUT parotitis
- **Orchitis, pancreatitis**

---

### **8. Other Viruses (Rare)**

- **Adenovirus**
- **Influenza A, B**
- **Epstein-Barr virus (EBV)**
- **Cytomegalovirus (CMV)** (immunocompromised)
- **Human herpesvirus 6 (HHV-6)**

---

## CSF FINDINGS

**Typical Viral Meningitis:**

| **Parameter** | **Bacterial Meningitis** | **Viral Meningitis** |
|---------------|--------------------------|----------------------|
| **WBC** | >1,000 (often >10,000) | **10-1,000** (usually 100-500) |
| **Differential** | **PMN predominance** (>80%) | **Lymphocyte predominance** (>50%)<br>**Early:** May have PMN predominance (first 24-48h) |
| **Glucose** | **<40 mg/dL** (CSF:serum <0.4) | **Normal** (>45 mg/dL, CSF:serum >0.6) |
| **Protein** | **>200 mg/dL** | **50-100 mg/dL** (mildly elevated or normal) |
| **Gram stain** | Positive (60-90%) | **Negative** |
| **Opening pressure** | Elevated (often >25 cm H2O) | Normal or mildly elevated (<25 cm H2O) |

**Key Point:** **Viral meningitis = lymphocyte predominance + normal glucose + mildly elevated protein**

---

**EXCEPTION: Early Viral Meningitis (First 24-48 Hours):**
- **May have PMN predominance** (initially)
- **Repeat LP at 12-24 hours** → Shift to lymphocyte predominance

---

**Viruses With Atypical CSF:**

**HSV, VZV, LCMV, Mumps:**
- **May have LOW glucose** (<40 mg/dL) - mimics bacterial/TB meningitis
- **Higher protein** (>100 mg/dL)

---

## DIAGNOSIS

---

### **Step 1: Obtain CSF**

**Studies:**
- **Cell count with differential**
- **Glucose, protein**
- **Gram stain, bacterial culture** (rule out bacterial)
- **Viral studies:**
  - **Enterovirus PCR** (if summer/fall)
  - **HSV-1/HSV-2 PCR** (if genital herpes history or recurrent meningitis)
  - **VZV PCR** (if zoster or varicella)
  - **West Nile Virus PCR** (if summer/fall, geographic area)
- **Consider:** HIV RNA PCR, LCMV PCR, mumps PCR

---

### **Step 2: Rule Out Bacterial Meningitis**

**If CSF Equivocal (PMN predominance, low glucose):**
- **Start empiric bacterial antibiotics** (vancomycin + ceftriaxone ± ampicillin)
- **Hold antibiotics** if:
  - **Bacterial culture negative at 24-48 hours**
  - **Clinical improvement**
  - **Viral PCR positive**

**Key Point:** **"When in doubt, treat as bacterial"** until cultures negative

---

### **Step 3: Viral-Specific Testing**

**Enterovirus PCR:**
- **Sensitivity:** 95-100%
- **Results:** 24-48 hours

**HSV PCR:**
- **Sensitivity:** 95% (HSV-1), 85% (HSV-2)
- **Can distinguish HSV-1 vs HSV-2**

**Serology (If PCR Unavailable):**
- **West Nile Virus IgM** (CSF or serum)
- **LCMV serology**
- **Mumps IgM**

---

## TREATMENT

---

### **1. Supportive Care (MOST Cases)**

**Management:**
- **Analgesics:** NSAIDs, acetaminophen (headache, fever)
- **Antiemetics:** Ondansetron (nausea/vomiting)
- **IV fluids** (if dehydrated)
- **Observation** (usually hospitalize 24-48h, then discharge if stable)

**Prognosis:**
- **Self-limited** (symptoms resolve in 7-10 days)
- **Full recovery** in >95%

**Key Point:** **No specific antiviral therapy for enterovirus meningitis** (supportive care only)

---

### **2. Antiviral Therapy (IF HSV, VZV)**

**HSV-2 Meningitis:**

**Primary Episode (First HSV-2 Outbreak With Meningitis):**
- **Acyclovir** 10 mg/kg IV q8h x **14-21 days**
- **OR Valacyclovir** 1g PO TID x 7-10 days (if mild, able to tolerate PO)

**Recurrent HSV-2 Meningitis (Mollaret):**
- **Acyclovir** 400 mg PO TID-5x/day x 5-7 days
- **Suppressive therapy** (if frequent recurrences): **Valacyclovir** 500 mg PO daily

---

**VZV Meningitis:**
- **Acyclovir** 10-15 mg/kg IV q8h x **10-14 days**

**Key Point:** **Treat HSV/VZV meningitis with acyclovir** (unlike enterovirus, which is supportive only)

---

### **3. Pleconaril (Enterovirus - NOT Routinely Available)**

**Status:**
- **NOT FDA-approved** (investigational)
- **Used in severe enterovirus infections** (neonates, immunocompromised)

---

## DIFFERENTIAL DIAGNOSIS OF LYMPHOCYTIC MENINGITIS

**"Aseptic Meningitis" = Negative Bacterial Cultures**

| **Etiology** | **Key Features** | **CSF Glucose** | **Diagnostic Test** |
|--------------|------------------|-----------------|---------------------|
| **Viral** (most common) | Summer/fall (enterovirus)<br>Self-limited | **Normal** | Enterovirus PCR, HSV PCR |
| **Tuberculous (TB)** | Subacute (weeks)<br>Immunocompromised<br>Basilar meningitis | **Low** (<40) | AFB smear/culture, TB PCR |
| **Fungal** (Cryptococcus) | Immunocompromised (HIV)<br>Subacute/chronic | **Low** | India ink, cryptococcal antigen |
| **Partially Treated Bacterial** | Prior antibiotics<br>Symptoms persist | **Low** | Bacterial PCR (if available) |
| **Lyme Disease** | Tick exposure, erythema migrans<br>Cranial nerve palsy (CN VII) | Normal | Lyme serology (CSF + serum), CSF antibody index |
| **Syphilis (Neurosyphilis)** | HIV, STI history | Normal or low | CSF VDRL (specific), serum RPR/TPPA |
| **Carcinomatous Meningitis** | Cancer history<br>Multiple cranial neuropathies | **Low** | Cytology (malignant cells) |
| **Medication-Induced** | NSAIDs, TMP-SMX, IVIG, monoclonal antibodies | Normal | History, resolution after stopping |
| **Autoimmune** | SLE, Sjögren's, sarcoidosis | Normal | Autoimmune workup (ANA, anti-Ro/La, ACE) |

**Key Point:** **If lymphocytic meningitis + low glucose → think TB, fungal, or partially treated bacterial**

---

## PROGNOSIS

**Viral Meningitis:**
- **Mortality:** <1%
- **Full recovery:** >95%
- **Duration:** Symptoms resolve in 7-10 days
- **Neurologic sequelae:** Rare (<5%) - mild headaches, fatigue

**Bacterial Meningitis (For Comparison):**
- **Mortality:** 10-30%
- **Neurologic sequelae:** 30-50%

---

## PREVENTION

**Vaccination:**
- **MMR:** Prevents mumps meningitis
- **Varicella vaccine:** Prevents VZV meningitis

**Mosquito Avoidance (Arboviruses):**
- DEET, protective clothing (summer/fall)

---

**Mnemonic: "ELVIS Has Viral Meningitis"**
- **E**nteroviruses (#1 cause - 85-90%)
- **L**CMVV (Lymphocytic choriomeningitis virus - rodent exposure)
- **V**ZV (Varicella-zoster virus - zoster)
- **I**HIV (Acute HIV syndrome)
- **S**SV-2 (HSV-2 - recurrent Mollaret meningitis)

**Mnemonic: "Lymphocytes + Normal Glucose = Viral"**
- **L**ymphocyte predominance
- **N**ormal glucose (>45 mg/dL)
- **V**iral meningitis

**Mnemonic: "HSV-2 = Recurrent, HSV-1 = Encephalitis"**
- **HSV-2** → Recurrent **m**eningitis (Mollaret)
- **HSV-1** → **E**ncephalitis (NOT meningitis)

**Clinical Pearls:**
- **Viral meningitis = benign, self-limited** (vs bacterial mortality 10-30%)
- **Enteroviruses = #1 cause** (85-90%), peak in summer/fall
- **CSF: Lymphocyte predominance + normal glucose + mildly elevated protein**
- **Exception:** Early viral meningitis (first 24-48h) may have PMN predominance → Repeat LP if unclear
- **HSV-2 = recurrent aseptic meningitis** (Mollaret syndrome)
- **HSV-1 = encephalitis** (NOT meningitis)
- **VZV meningitis may occur WITHOUT rash** (zoster sine herpete)
- **If lymphocytic meningitis + LOW glucose → TB, fungal, or partially treated bacterial** (NOT typical viral)
- **Treatment: Supportive care** (most cases) - NO antiviral for enterovirus
- **Acyclovir for HSV/VZV meningitis** (10 mg/kg IV q8h)
- **Enterovirus PCR sensitivity 95-100%** (gold standard)
- **When in doubt, treat as bacterial** until cultures negative (do NOT withhold antibiotics)
- **Prognosis: Full recovery >95%**, symptoms resolve 7-10 days
- **West Nile Virus = most common arboviral CNS infection** in US (summer/fall)

**Media:** None

**Sources:** [IDSA 2008 - Encephalitis and Meningitis Guidelines], [NEJM 2021 - Viral meningitis], [Clinical Infectious Diseases 2023 - Enterovirus meningitis], [Lancet Neurology 2024 - HSV-2 recurrent meningitis], [CDC 2024 - West Nile Virus surveillance]
